nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—Neuropathy—Capecitabine—esophageal cancer	0.00367	0.00426	CcSEcCtD
Tizanidine—Petechiae—Methotrexate—esophageal cancer	0.00354	0.0041	CcSEcCtD
Tizanidine—Ecchymosis—Capecitabine—esophageal cancer	0.00353	0.0041	CcSEcCtD
Tizanidine—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00352	0.00408	CcSEcCtD
Tizanidine—Hypokalaemia—Cisplatin—esophageal cancer	0.0035	0.00406	CcSEcCtD
Tizanidine—Mental disability—Capecitabine—esophageal cancer	0.00339	0.00393	CcSEcCtD
Tizanidine—Sepsis—Capecitabine—esophageal cancer	0.00339	0.00393	CcSEcCtD
Tizanidine—Speech disorder—Methotrexate—esophageal cancer	0.00338	0.00392	CcSEcCtD
Tizanidine—Ear pain—Capecitabine—esophageal cancer	0.00333	0.00386	CcSEcCtD
Tizanidine—Phlebitis—Capecitabine—esophageal cancer	0.00329	0.00382	CcSEcCtD
Tizanidine—Hepatic function abnormal—Capecitabine—esophageal cancer	0.00325	0.00377	CcSEcCtD
Tizanidine—Gastroenteritis—Capecitabine—esophageal cancer	0.0032	0.00371	CcSEcCtD
Tizanidine—Vascular purpura—Capecitabine—esophageal cancer	0.00317	0.00368	CcSEcCtD
Tizanidine—Deafness—Capecitabine—esophageal cancer	0.00317	0.00368	CcSEcCtD
Tizanidine—Herpes simplex—Methotrexate—esophageal cancer	0.00316	0.00366	CcSEcCtD
Tizanidine—Hepatic failure—Capecitabine—esophageal cancer	0.00316	0.00366	CcSEcCtD
Tizanidine—Eye pain—Capecitabine—esophageal cancer	0.00314	0.00365	CcSEcCtD
Tizanidine—Renal failure acute—Capecitabine—esophageal cancer	0.00307	0.00356	CcSEcCtD
Tizanidine—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.00301	0.00349	CcSEcCtD
Tizanidine—Purpura—Capecitabine—esophageal cancer	0.00294	0.00341	CcSEcCtD
Tizanidine—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00292	0.00339	CcSEcCtD
Tizanidine—Arthritis—Capecitabine—esophageal cancer	0.00292	0.00339	CcSEcCtD
Tizanidine—Renal failure—Cisplatin—esophageal cancer	0.00292	0.00338	CcSEcCtD
Tizanidine—Vaginal inflammation—Methotrexate—esophageal cancer	0.00291	0.00337	CcSEcCtD
Tizanidine—Pulmonary embolism—Methotrexate—esophageal cancer	0.00291	0.00337	CcSEcCtD
Tizanidine—Myocardial infarction—Cisplatin—esophageal cancer	0.00291	0.00337	CcSEcCtD
Tizanidine—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00291	0.00337	CcSEcCtD
Tizanidine—Cardiac failure—Capecitabine—esophageal cancer	0.00291	0.00337	CcSEcCtD
Tizanidine—Cerebrovascular accident—Capecitabine—esophageal cancer	0.0029	0.00336	CcSEcCtD
Tizanidine—Conjunctivitis—Cisplatin—esophageal cancer	0.00288	0.00334	CcSEcCtD
Tizanidine—Hyponatraemia—Capecitabine—esophageal cancer	0.00285	0.0033	CcSEcCtD
Tizanidine—Cystitis noninfective—Methotrexate—esophageal cancer	0.00284	0.0033	CcSEcCtD
Tizanidine—Melaena—Methotrexate—esophageal cancer	0.00284	0.0033	CcSEcCtD
Tizanidine—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.00284	0.00329	CcSEcCtD
Tizanidine—Cystitis—Methotrexate—esophageal cancer	0.00281	0.00326	CcSEcCtD
Tizanidine—Depressed level of consciousness—Methotrexate—esophageal cancer	0.00281	0.00326	CcSEcCtD
Tizanidine—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00281	0.00325	CcSEcCtD
Tizanidine—Migraine—Capecitabine—esophageal cancer	0.00279	0.00324	CcSEcCtD
Tizanidine—Vaginal infection—Methotrexate—esophageal cancer	0.00275	0.00319	CcSEcCtD
Tizanidine—Bradycardia—Cisplatin—esophageal cancer	0.00271	0.00314	CcSEcCtD
Tizanidine—Cardiac arrest—Capecitabine—esophageal cancer	0.0027	0.00313	CcSEcCtD
Tizanidine—Urinary retention—Capecitabine—esophageal cancer	0.0027	0.00313	CcSEcCtD
Tizanidine—Mood swings—Capecitabine—esophageal cancer	0.00269	0.00312	CcSEcCtD
Tizanidine—Bladder pain—Methotrexate—esophageal cancer	0.00263	0.00305	CcSEcCtD
Tizanidine—Ecchymosis—Methotrexate—esophageal cancer	0.00263	0.00305	CcSEcCtD
Tizanidine—Urinary tract disorder—Cisplatin—esophageal cancer	0.00263	0.00305	CcSEcCtD
Tizanidine—Liver function test abnormal—Capecitabine—esophageal cancer	0.00262	0.00304	CcSEcCtD
Tizanidine—Connective tissue disorder—Cisplatin—esophageal cancer	0.00262	0.00303	CcSEcCtD
Tizanidine—Urethral disorder—Cisplatin—esophageal cancer	0.00261	0.00303	CcSEcCtD
Tizanidine—Dry skin—Capecitabine—esophageal cancer	0.0026	0.00302	CcSEcCtD
Tizanidine—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00259	0.00301	CcSEcCtD
Tizanidine—Pulmonary oedema—Methotrexate—esophageal cancer	0.00259	0.003	CcSEcCtD
Tizanidine—Hypokalaemia—Capecitabine—esophageal cancer	0.00258	0.00299	CcSEcCtD
Tizanidine—Sepsis—Methotrexate—esophageal cancer	0.00252	0.00293	CcSEcCtD
Tizanidine—Muscular weakness—Capecitabine—esophageal cancer	0.0025	0.0029	CcSEcCtD
Tizanidine—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.0025	0.0029	CcSEcCtD
Tizanidine—Tinnitus—Cisplatin—esophageal cancer	0.00248	0.00288	CcSEcCtD
Tizanidine—Cardiac disorder—Cisplatin—esophageal cancer	0.00247	0.00287	CcSEcCtD
Tizanidine—Influenza—Capecitabine—esophageal cancer	0.00245	0.00284	CcSEcCtD
Tizanidine—Dysphagia—Capecitabine—esophageal cancer	0.00245	0.00284	CcSEcCtD
Tizanidine—Asthma—Capecitabine—esophageal cancer	0.00245	0.00284	CcSEcCtD
Tizanidine—Immune system disorder—Cisplatin—esophageal cancer	0.0024	0.00279	CcSEcCtD
Tizanidine—Mediastinal disorder—Cisplatin—esophageal cancer	0.0024	0.00278	CcSEcCtD
Tizanidine—Angina pectoris—Capecitabine—esophageal cancer	0.00239	0.00277	CcSEcCtD
Tizanidine—Arrhythmia—Cisplatin—esophageal cancer	0.00238	0.00276	CcSEcCtD
Tizanidine—Bronchitis—Capecitabine—esophageal cancer	0.00236	0.00274	CcSEcCtD
Tizanidine—Alopecia—Cisplatin—esophageal cancer	0.00235	0.00273	CcSEcCtD
Tizanidine—Hepatic failure—Methotrexate—esophageal cancer	0.00235	0.00273	CcSEcCtD
Tizanidine—Renal failure acute—Methotrexate—esophageal cancer	0.00229	0.00265	CcSEcCtD
Tizanidine—Flatulence—Cisplatin—esophageal cancer	0.00228	0.00265	CcSEcCtD
Tizanidine—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.00224	0.0026	CcSEcCtD
Tizanidine—Muscle spasms—Cisplatin—esophageal cancer	0.00223	0.00258	CcSEcCtD
Tizanidine—Weight decreased—Capecitabine—esophageal cancer	0.00222	0.00257	CcSEcCtD
Tizanidine—Hyperglycaemia—Capecitabine—esophageal cancer	0.00221	0.00257	CcSEcCtD
Tizanidine—Pneumonia—Capecitabine—esophageal cancer	0.0022	0.00255	CcSEcCtD
Tizanidine—Vision blurred—Cisplatin—esophageal cancer	0.00218	0.00253	CcSEcCtD
Tizanidine—Depression—Capecitabine—esophageal cancer	0.00218	0.00253	CcSEcCtD
Tizanidine—Tremor—Cisplatin—esophageal cancer	0.00217	0.00252	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.00217	0.00251	CcSEcCtD
Tizanidine—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00216	0.0025	CcSEcCtD
Tizanidine—Cerebrovascular accident—Methotrexate—esophageal cancer	0.00216	0.0025	CcSEcCtD
Tizanidine—Ill-defined disorder—Cisplatin—esophageal cancer	0.00215	0.00249	CcSEcCtD
Tizanidine—Renal failure—Capecitabine—esophageal cancer	0.00215	0.00249	CcSEcCtD
Tizanidine—Myocardial infarction—Capecitabine—esophageal cancer	0.00214	0.00249	CcSEcCtD
Tizanidine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00214	0.00249	CcSEcCtD
Tizanidine—Anaemia—Cisplatin—esophageal cancer	0.00214	0.00248	CcSEcCtD
Tizanidine—Jaundice—Capecitabine—esophageal cancer	0.00213	0.00247	CcSEcCtD
Tizanidine—Conjunctivitis—Capecitabine—esophageal cancer	0.00213	0.00246	CcSEcCtD
Tizanidine—Malaise—Cisplatin—esophageal cancer	0.00209	0.00242	CcSEcCtD
Tizanidine—Haematuria—Capecitabine—esophageal cancer	0.00208	0.00242	CcSEcCtD
Tizanidine—Leukopenia—Cisplatin—esophageal cancer	0.00207	0.00241	CcSEcCtD
Tizanidine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00207	0.0024	CcSEcCtD
Tizanidine—Agranulocytosis—Capecitabine—esophageal cancer	0.00204	0.00237	CcSEcCtD
Tizanidine—Convulsion—Cisplatin—esophageal cancer	0.00201	0.00233	CcSEcCtD
Tizanidine—Mood swings—Methotrexate—esophageal cancer	0.002	0.00232	CcSEcCtD
Tizanidine—Bradycardia—Capecitabine—esophageal cancer	0.002	0.00232	CcSEcCtD
Tizanidine—Haemoglobin—Capecitabine—esophageal cancer	0.00197	0.00229	CcSEcCtD
Tizanidine—Rhinitis—Capecitabine—esophageal cancer	0.00197	0.00228	CcSEcCtD
Tizanidine—Anxiety—Cisplatin—esophageal cancer	0.00197	0.00228	CcSEcCtD
Tizanidine—Hepatitis—Capecitabine—esophageal cancer	0.00196	0.00228	CcSEcCtD
Tizanidine—Haemorrhage—Capecitabine—esophageal cancer	0.00196	0.00228	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00196	0.00227	CcSEcCtD
Tizanidine—Liver function test abnormal—Methotrexate—esophageal cancer	0.00195	0.00226	CcSEcCtD
Tizanidine—Discomfort—Cisplatin—esophageal cancer	0.00195	0.00226	CcSEcCtD
Tizanidine—Pharyngitis—Capecitabine—esophageal cancer	0.00195	0.00226	CcSEcCtD
Tizanidine—Urinary tract disorder—Capecitabine—esophageal cancer	0.00194	0.00225	CcSEcCtD
Tizanidine—Connective tissue disorder—Capecitabine—esophageal cancer	0.00193	0.00224	CcSEcCtD
Tizanidine—Urethral disorder—Capecitabine—esophageal cancer	0.00192	0.00223	CcSEcCtD
Tizanidine—Anaphylactic shock—Cisplatin—esophageal cancer	0.00189	0.00219	CcSEcCtD
Tizanidine—Oedema—Cisplatin—esophageal cancer	0.00189	0.00219	CcSEcCtD
Tizanidine—Infection—Cisplatin—esophageal cancer	0.00188	0.00218	CcSEcCtD
Tizanidine—Erythema multiforme—Capecitabine—esophageal cancer	0.00186	0.00215	CcSEcCtD
Tizanidine—Nervous system disorder—Cisplatin—esophageal cancer	0.00186	0.00215	CcSEcCtD
Tizanidine—Thrombocytopenia—Cisplatin—esophageal cancer	0.00185	0.00215	CcSEcCtD
Tizanidine—Tachycardia—Cisplatin—esophageal cancer	0.00185	0.00214	CcSEcCtD
Tizanidine—Skin disorder—Cisplatin—esophageal cancer	0.00184	0.00213	CcSEcCtD
Tizanidine—Tinnitus—Capecitabine—esophageal cancer	0.00183	0.00212	CcSEcCtD
Tizanidine—Hyperhidrosis—Cisplatin—esophageal cancer	0.00183	0.00212	CcSEcCtD
Tizanidine—Asthma—Methotrexate—esophageal cancer	0.00183	0.00212	CcSEcCtD
Tizanidine—Cardiac disorder—Capecitabine—esophageal cancer	0.00182	0.00211	CcSEcCtD
Tizanidine—Angiopathy—Capecitabine—esophageal cancer	0.00178	0.00207	CcSEcCtD
Tizanidine—Immune system disorder—Capecitabine—esophageal cancer	0.00177	0.00206	CcSEcCtD
Tizanidine—Mediastinal disorder—Capecitabine—esophageal cancer	0.00177	0.00205	CcSEcCtD
Tizanidine—Hypotension—Cisplatin—esophageal cancer	0.00177	0.00205	CcSEcCtD
Tizanidine—Arrhythmia—Capecitabine—esophageal cancer	0.00175	0.00203	CcSEcCtD
Tizanidine—Alopecia—Capecitabine—esophageal cancer	0.00173	0.00201	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00172	0.002	CcSEcCtD
Tizanidine—Mental disorder—Capecitabine—esophageal cancer	0.00172	0.00199	CcSEcCtD
Tizanidine—Paraesthesia—Cisplatin—esophageal cancer	0.0017	0.00197	CcSEcCtD
Tizanidine—Dyspnoea—Cisplatin—esophageal cancer	0.00169	0.00196	CcSEcCtD
Tizanidine—Flatulence—Capecitabine—esophageal cancer	0.00168	0.00195	CcSEcCtD
Tizanidine—Back pain—Capecitabine—esophageal cancer	0.00165	0.00192	CcSEcCtD
Tizanidine—Muscle spasms—Capecitabine—esophageal cancer	0.00164	0.00191	CcSEcCtD
Tizanidine—Pneumonia—Methotrexate—esophageal cancer	0.00164	0.0019	CcSEcCtD
Tizanidine—Drowsiness—Methotrexate—esophageal cancer	0.00163	0.00189	CcSEcCtD
Tizanidine—Depression—Methotrexate—esophageal cancer	0.00162	0.00188	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00161	0.00187	CcSEcCtD
Tizanidine—Vision blurred—Capecitabine—esophageal cancer	0.00161	0.00187	CcSEcCtD
Tizanidine—Tremor—Capecitabine—esophageal cancer	0.0016	0.00186	CcSEcCtD
Tizanidine—Renal failure—Methotrexate—esophageal cancer	0.0016	0.00186	CcSEcCtD
Tizanidine—Ill-defined disorder—Capecitabine—esophageal cancer	0.00159	0.00184	CcSEcCtD
Tizanidine—Conjunctivitis—Methotrexate—esophageal cancer	0.00158	0.00183	CcSEcCtD
Tizanidine—Anaemia—Capecitabine—esophageal cancer	0.00158	0.00183	CcSEcCtD
Tizanidine—Sweating—Methotrexate—esophageal cancer	0.00156	0.00181	CcSEcCtD
Tizanidine—Feeling abnormal—Cisplatin—esophageal cancer	0.00156	0.00181	CcSEcCtD
Tizanidine—Haematuria—Methotrexate—esophageal cancer	0.00155	0.0018	CcSEcCtD
Tizanidine—Malaise—Capecitabine—esophageal cancer	0.00154	0.00179	CcSEcCtD
Tizanidine—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00154	0.00179	CcSEcCtD
Tizanidine—Vertigo—Capecitabine—esophageal cancer	0.00154	0.00178	CcSEcCtD
Tizanidine—Syncope—Capecitabine—esophageal cancer	0.00153	0.00178	CcSEcCtD
Tizanidine—Leukopenia—Capecitabine—esophageal cancer	0.00153	0.00177	CcSEcCtD
Tizanidine—Agranulocytosis—Methotrexate—esophageal cancer	0.00152	0.00176	CcSEcCtD
Tizanidine—Loss of consciousness—Capecitabine—esophageal cancer	0.0015	0.00174	CcSEcCtD
Tizanidine—Body temperature increased—Cisplatin—esophageal cancer	0.0015	0.00173	CcSEcCtD
Tizanidine—Hypertension—Capecitabine—esophageal cancer	0.00148	0.00171	CcSEcCtD
Tizanidine—Haemoglobin—Methotrexate—esophageal cancer	0.00147	0.0017	CcSEcCtD
Tizanidine—Hepatitis—Methotrexate—esophageal cancer	0.00146	0.00169	CcSEcCtD
Tizanidine—Haemorrhage—Methotrexate—esophageal cancer	0.00146	0.00169	CcSEcCtD
Tizanidine—Arthralgia—Capecitabine—esophageal cancer	0.00145	0.00169	CcSEcCtD
Tizanidine—Pharyngitis—Methotrexate—esophageal cancer	0.00145	0.00168	CcSEcCtD
Tizanidine—Anxiety—Capecitabine—esophageal cancer	0.00145	0.00168	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00144	0.00168	CcSEcCtD
Tizanidine—Urinary tract disorder—Methotrexate—esophageal cancer	0.00144	0.00167	CcSEcCtD
Tizanidine—Discomfort—Capecitabine—esophageal cancer	0.00144	0.00167	CcSEcCtD
Tizanidine—Urethral disorder—Methotrexate—esophageal cancer	0.00143	0.00166	CcSEcCtD
Tizanidine—Dry mouth—Capecitabine—esophageal cancer	0.00142	0.00165	CcSEcCtD
Tizanidine—Confusional state—Capecitabine—esophageal cancer	0.00141	0.00163	CcSEcCtD
Tizanidine—Oedema—Capecitabine—esophageal cancer	0.00139	0.00162	CcSEcCtD
Tizanidine—Hypersensitivity—Cisplatin—esophageal cancer	0.00139	0.00162	CcSEcCtD
Tizanidine—Infection—Capecitabine—esophageal cancer	0.00139	0.00161	CcSEcCtD
Tizanidine—Erythema multiforme—Methotrexate—esophageal cancer	0.00138	0.0016	CcSEcCtD
Tizanidine—Shock—Capecitabine—esophageal cancer	0.00137	0.00159	CcSEcCtD
Tizanidine—Nervous system disorder—Capecitabine—esophageal cancer	0.00137	0.00159	CcSEcCtD
Tizanidine—Thrombocytopenia—Capecitabine—esophageal cancer	0.00137	0.00158	CcSEcCtD
Tizanidine—Tinnitus—Methotrexate—esophageal cancer	0.00136	0.00158	CcSEcCtD
Tizanidine—Tachycardia—Capecitabine—esophageal cancer	0.00136	0.00158	CcSEcCtD
Tizanidine—Asthenia—Cisplatin—esophageal cancer	0.00136	0.00157	CcSEcCtD
Tizanidine—Cardiac disorder—Methotrexate—esophageal cancer	0.00136	0.00157	CcSEcCtD
Tizanidine—Skin disorder—Capecitabine—esophageal cancer	0.00135	0.00157	CcSEcCtD
Tizanidine—Hyperhidrosis—Capecitabine—esophageal cancer	0.00135	0.00156	CcSEcCtD
Tizanidine—Angiopathy—Methotrexate—esophageal cancer	0.00133	0.00154	CcSEcCtD
Tizanidine—Immune system disorder—Methotrexate—esophageal cancer	0.00132	0.00153	CcSEcCtD
Tizanidine—Mediastinal disorder—Methotrexate—esophageal cancer	0.00132	0.00153	CcSEcCtD
Tizanidine—Hypotension—Capecitabine—esophageal cancer	0.0013	0.00151	CcSEcCtD
Tizanidine—Diarrhoea—Cisplatin—esophageal cancer	0.00129	0.0015	CcSEcCtD
Tizanidine—Alopecia—Methotrexate—esophageal cancer	0.00129	0.0015	CcSEcCtD
Tizanidine—Mental disorder—Methotrexate—esophageal cancer	0.00128	0.00148	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00127	0.00147	CcSEcCtD
Tizanidine—Paraesthesia—Capecitabine—esophageal cancer	0.00125	0.00145	CcSEcCtD
Tizanidine—Dyspnoea—Capecitabine—esophageal cancer	0.00124	0.00144	CcSEcCtD
Tizanidine—Back pain—Methotrexate—esophageal cancer	0.00123	0.00143	CcSEcCtD
Tizanidine—Dyspepsia—Capecitabine—esophageal cancer	0.00123	0.00142	CcSEcCtD
Tizanidine—Vomiting—Cisplatin—esophageal cancer	0.0012	0.0014	CcSEcCtD
Tizanidine—Fatigue—Capecitabine—esophageal cancer	0.0012	0.00139	CcSEcCtD
Tizanidine—Vision blurred—Methotrexate—esophageal cancer	0.0012	0.00139	CcSEcCtD
Tizanidine—Rash—Cisplatin—esophageal cancer	0.00119	0.00138	CcSEcCtD
Tizanidine—Constipation—Capecitabine—esophageal cancer	0.00119	0.00138	CcSEcCtD
Tizanidine—Dermatitis—Cisplatin—esophageal cancer	0.00119	0.00138	CcSEcCtD
Tizanidine—Ill-defined disorder—Methotrexate—esophageal cancer	0.00118	0.00137	CcSEcCtD
Tizanidine—Anaemia—Methotrexate—esophageal cancer	0.00118	0.00136	CcSEcCtD
Tizanidine—Feeling abnormal—Capecitabine—esophageal cancer	0.00115	0.00133	CcSEcCtD
Tizanidine—Malaise—Methotrexate—esophageal cancer	0.00115	0.00133	CcSEcCtD
Tizanidine—Vertigo—Methotrexate—esophageal cancer	0.00114	0.00133	CcSEcCtD
Tizanidine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00114	0.00132	CcSEcCtD
Tizanidine—Leukopenia—Methotrexate—esophageal cancer	0.00114	0.00132	CcSEcCtD
Tizanidine—Nausea—Cisplatin—esophageal cancer	0.00112	0.0013	CcSEcCtD
Tizanidine—Urticaria—Capecitabine—esophageal cancer	0.00111	0.00128	CcSEcCtD
Tizanidine—Body temperature increased—Capecitabine—esophageal cancer	0.0011	0.00128	CcSEcCtD
Tizanidine—Abdominal pain—Capecitabine—esophageal cancer	0.0011	0.00128	CcSEcCtD
Tizanidine—Convulsion—Methotrexate—esophageal cancer	0.0011	0.00128	CcSEcCtD
Tizanidine—Arthralgia—Methotrexate—esophageal cancer	0.00108	0.00126	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00108	0.00125	CcSEcCtD
Tizanidine—Discomfort—Methotrexate—esophageal cancer	0.00107	0.00124	CcSEcCtD
Tizanidine—Confusional state—Methotrexate—esophageal cancer	0.00105	0.00121	CcSEcCtD
Tizanidine—Anaphylactic shock—Methotrexate—esophageal cancer	0.00104	0.0012	CcSEcCtD
Tizanidine—Infection—Methotrexate—esophageal cancer	0.00103	0.0012	CcSEcCtD
Tizanidine—Hypersensitivity—Capecitabine—esophageal cancer	0.00103	0.00119	CcSEcCtD
Tizanidine—Nervous system disorder—Methotrexate—esophageal cancer	0.00102	0.00118	CcSEcCtD
Tizanidine—Thrombocytopenia—Methotrexate—esophageal cancer	0.00102	0.00118	CcSEcCtD
Tizanidine—Skin disorder—Methotrexate—esophageal cancer	0.00101	0.00117	CcSEcCtD
Tizanidine—Hyperhidrosis—Methotrexate—esophageal cancer	0.001	0.00116	CcSEcCtD
Tizanidine—Asthenia—Capecitabine—esophageal cancer	0.001	0.00116	CcSEcCtD
Tizanidine—Pruritus—Capecitabine—esophageal cancer	0.000987	0.00114	CcSEcCtD
Tizanidine—Hypotension—Methotrexate—esophageal cancer	0.00097	0.00113	CcSEcCtD
Tizanidine—Diarrhoea—Capecitabine—esophageal cancer	0.000954	0.00111	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000946	0.0011	CcSEcCtD
Tizanidine—Paraesthesia—Methotrexate—esophageal cancer	0.000932	0.00108	CcSEcCtD
Tizanidine—Dyspnoea—Methotrexate—esophageal cancer	0.000925	0.00107	CcSEcCtD
Tizanidine—Somnolence—Methotrexate—esophageal cancer	0.000923	0.00107	CcSEcCtD
Tizanidine—Dizziness—Capecitabine—esophageal cancer	0.000922	0.00107	CcSEcCtD
Tizanidine—Dyspepsia—Methotrexate—esophageal cancer	0.000914	0.00106	CcSEcCtD
Tizanidine—Fatigue—Methotrexate—esophageal cancer	0.000895	0.00104	CcSEcCtD
Tizanidine—Vomiting—Capecitabine—esophageal cancer	0.000887	0.00103	CcSEcCtD
Tizanidine—Rash—Capecitabine—esophageal cancer	0.000879	0.00102	CcSEcCtD
Tizanidine—Dermatitis—Capecitabine—esophageal cancer	0.000878	0.00102	CcSEcCtD
Tizanidine—Feeling abnormal—Methotrexate—esophageal cancer	0.000855	0.000992	CcSEcCtD
Tizanidine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000849	0.000985	CcSEcCtD
Tizanidine—Nausea—Capecitabine—esophageal cancer	0.000828	0.000961	CcSEcCtD
Tizanidine—Urticaria—Methotrexate—esophageal cancer	0.000825	0.000956	CcSEcCtD
Tizanidine—Abdominal pain—Methotrexate—esophageal cancer	0.000821	0.000952	CcSEcCtD
Tizanidine—Body temperature increased—Methotrexate—esophageal cancer	0.000821	0.000952	CcSEcCtD
Tizanidine—Hypersensitivity—Methotrexate—esophageal cancer	0.000765	0.000887	CcSEcCtD
Tizanidine—Asthenia—Methotrexate—esophageal cancer	0.000745	0.000864	CcSEcCtD
Tizanidine—Pruritus—Methotrexate—esophageal cancer	0.000734	0.000852	CcSEcCtD
Tizanidine—Diarrhoea—Methotrexate—esophageal cancer	0.00071	0.000824	CcSEcCtD
Tizanidine—Dizziness—Methotrexate—esophageal cancer	0.000686	0.000796	CcSEcCtD
Tizanidine—Vomiting—Methotrexate—esophageal cancer	0.00066	0.000766	CcSEcCtD
Tizanidine—Rash—Methotrexate—esophageal cancer	0.000655	0.000759	CcSEcCtD
Tizanidine—Dermatitis—Methotrexate—esophageal cancer	0.000654	0.000758	CcSEcCtD
Tizanidine—Nausea—Methotrexate—esophageal cancer	0.000617	0.000715	CcSEcCtD
Tizanidine—ADRA2C—Metabolism—TYMP—esophageal cancer	0.00015	0.00109	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—WIF1—esophageal cancer	0.00015	0.00109	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—GNG7—esophageal cancer	0.00015	0.00109	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CSNK1A1—esophageal cancer	0.000148	0.00108	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CXCL2—esophageal cancer	0.000148	0.00107	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—SST—esophageal cancer	0.000147	0.00107	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—ANXA1—esophageal cancer	0.000147	0.00107	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CYP26A1—esophageal cancer	0.000146	0.00106	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PLCE1—esophageal cancer	0.000146	0.00106	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ADH7—esophageal cancer	0.000146	0.00106	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000144	0.00104	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ADCYAP1—esophageal cancer	0.000143	0.00104	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—GHRL—esophageal cancer	0.000143	0.00104	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—ABL1—esophageal cancer	0.000143	0.00104	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PDE4D—esophageal cancer	0.000143	0.00104	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—SST—esophageal cancer	0.000143	0.00104	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ALOX15—esophageal cancer	0.000143	0.00103	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—GHRL—esophageal cancer	0.000139	0.00101	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PFN1—esophageal cancer	0.000139	0.00101	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CSNK1A1—esophageal cancer	0.000138	0.001	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—ANXA1—esophageal cancer	0.000137	0.000995	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—GNG7—esophageal cancer	0.000136	0.000987	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—TPI1—esophageal cancer	0.000136	0.000987	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—GSTO1—esophageal cancer	0.000136	0.000987	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—NOS2—esophageal cancer	0.000136	0.000987	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—SST—esophageal cancer	0.000133	0.000968	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CXCL2—esophageal cancer	0.000132	0.000958	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—WWOX—esophageal cancer	0.000131	0.000951	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ALDOB—esophageal cancer	0.00013	0.000946	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—GHRL—esophageal cancer	0.00013	0.000944	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PFN1—esophageal cancer	0.00013	0.00094	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ADH1B—esophageal cancer	0.000128	0.000927	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—NOS2—esophageal cancer	0.000127	0.000922	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—GAPDH—esophageal cancer	0.000126	0.000911	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000125	0.000909	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FKBP1A—esophageal cancer	0.000125	0.000905	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ELMO1—esophageal cancer	0.000125	0.000904	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CRABP1—esophageal cancer	0.000124	0.000903	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—ANXA1—esophageal cancer	0.000123	0.00089	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—TYMP—esophageal cancer	0.000122	0.000886	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—CREBBP—esophageal cancer	0.000122	0.000886	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—WIF1—esophageal cancer	0.000122	0.000884	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AKAP13—esophageal cancer	0.000122	0.000883	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CXCL2—esophageal cancer	0.00012	0.00087	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—SST—esophageal cancer	0.000119	0.000866	CbGpPWpGaD
Tizanidine—ADRA2B—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	0.000119	0.000866	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CYP26A1—esophageal cancer	0.000119	0.000862	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—GNG7—esophageal cancer	0.000118	0.000858	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ELMO1—esophageal cancer	0.000116	0.000844	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—GHRL—esophageal cancer	0.000116	0.000844	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ALOX15—esophageal cancer	0.000116	0.00084	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—CREBBP—esophageal cancer	0.000114	0.000828	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AKAP13—esophageal cancer	0.000114	0.000825	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CSNK1A1—esophageal cancer	0.000112	0.000816	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000112	0.000815	CbGpPWpGaD
Tizanidine—ADRA2C—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	0.000111	0.000809	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—ANXA1—esophageal cancer	0.000111	0.000808	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PDE4D—esophageal cancer	0.000111	0.000808	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SLC52A3—esophageal cancer	0.000111	0.000808	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—BLVRB—esophageal cancer	0.000111	0.000808	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ALDH2—esophageal cancer	0.000111	0.000804	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—TPI1—esophageal cancer	0.00011	0.000802	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GSTO1—esophageal cancer	0.00011	0.000802	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—NOS3—esophageal cancer	0.000109	0.000793	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—SST—esophageal cancer	0.000108	0.000786	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—GNG7—esophageal cancer	0.000106	0.000768	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ALDOB—esophageal cancer	0.000106	0.000768	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—GHRL—esophageal cancer	0.000106	0.000766	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—GSTT1—esophageal cancer	0.000105	0.000765	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PFN1—esophageal cancer	0.000105	0.000763	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000105	0.000762	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CYP2A6—esophageal cancer	0.000104	0.000756	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PDE4D—esophageal cancer	0.000104	0.000755	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—NOS2—esophageal cancer	0.000103	0.000749	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—NOS3—esophageal cancer	0.000102	0.000741	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GAPDH—esophageal cancer	0.000102	0.00074	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CRABP1—esophageal cancer	0.000101	0.000733	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	9.95e-05	0.000722	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—XIAP—esophageal cancer	9.93e-05	0.00072	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—GNG7—esophageal cancer	9.89e-05	0.000718	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PTGS1—esophageal cancer	9.88e-05	0.000717	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ENO1—esophageal cancer	9.88e-05	0.000717	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PSME2—esophageal cancer	9.74e-05	0.000707	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PSME1—esophageal cancer	9.74e-05	0.000707	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GNG7—esophageal cancer	9.61e-05	0.000697	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CA1—esophageal cancer	9.46e-05	0.000687	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SLC10A2—esophageal cancer	9.46e-05	0.000687	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ELMO1—esophageal cancer	9.45e-05	0.000686	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CTNNA1—esophageal cancer	9.39e-05	0.000681	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CXCL2—esophageal cancer	9.33e-05	0.000677	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—XIAP—esophageal cancer	9.27e-05	0.000673	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—CREBBP—esophageal cancer	9.27e-05	0.000672	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AKAP13—esophageal cancer	9.24e-05	0.00067	CbGpPWpGaD
Tizanidine—ADRA2A—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	9.06e-05	0.000657	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ALDH2—esophageal cancer	9.01e-05	0.000653	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CTNNA1—esophageal cancer	8.77e-05	0.000636	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PSME2—esophageal cancer	8.72e-05	0.000632	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PSME1—esophageal cancer	8.72e-05	0.000632	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CXCL2—esophageal cancer	8.72e-05	0.000632	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ANXA1—esophageal cancer	8.68e-05	0.000629	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CA2—esophageal cancer	8.66e-05	0.000628	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GSTT1—esophageal cancer	8.57e-05	0.000622	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HIST1H2BM—esophageal cancer	8.53e-05	0.000619	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CYP2A6—esophageal cancer	8.47e-05	0.000614	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	8.46e-05	0.000614	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PDE4D—esophageal cancer	8.45e-05	0.000613	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SST—esophageal cancer	8.44e-05	0.000612	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CYP1B1—esophageal cancer	8.4e-05	0.00061	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—EP300—esophageal cancer	8.32e-05	0.000603	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—NOS3—esophageal cancer	8.3e-05	0.000602	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NOTCH3—esophageal cancer	8.22e-05	0.000597	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—GHRL—esophageal cancer	8.22e-05	0.000597	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PSME2—esophageal cancer	8.14e-05	0.000591	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PSME1—esophageal cancer	8.14e-05	0.000591	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ANXA1—esophageal cancer	8.1e-05	0.000588	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—FBXW7—esophageal cancer	8.09e-05	0.000587	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ADH7—esophageal cancer	8.05e-05	0.000584	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PLCE1—esophageal cancer	8.05e-05	0.000584	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—GNG7—esophageal cancer	8.04e-05	0.000583	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ENO1—esophageal cancer	8.03e-05	0.000582	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PTGS1—esophageal cancer	8.03e-05	0.000582	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	7.95e-05	0.000577	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PSME2—esophageal cancer	7.91e-05	0.000574	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PSME1—esophageal cancer	7.91e-05	0.000574	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CYP19A1—esophageal cancer	7.9e-05	0.000573	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SST—esophageal cancer	7.88e-05	0.000572	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—EP300—esophageal cancer	7.77e-05	0.000564	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NOTCH3—esophageal cancer	7.68e-05	0.000557	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—GHRL—esophageal cancer	7.68e-05	0.000557	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—FBXW7—esophageal cancer	7.56e-05	0.000548	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—XIAP—esophageal cancer	7.53e-05	0.000546	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NOTCH2—esophageal cancer	7.38e-05	0.000535	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—HMOX1—esophageal cancer	7.21e-05	0.000523	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CTNNA1—esophageal cancer	7.12e-05	0.000517	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CXCL2—esophageal cancer	7.08e-05	0.000514	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ADH1B—esophageal cancer	7.06e-05	0.000512	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ABCB1—esophageal cancer	6.92e-05	0.000502	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NOTCH2—esophageal cancer	6.89e-05	0.0005	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CYP1B1—esophageal cancer	6.83e-05	0.000495	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—TYMP—esophageal cancer	6.74e-05	0.000489	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PSME1—esophageal cancer	6.61e-05	0.00048	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PSME2—esophageal cancer	6.61e-05	0.00048	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ANXA1—esophageal cancer	6.58e-05	0.000478	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP26A1—esophageal cancer	6.56e-05	0.000476	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TGFBR2—esophageal cancer	6.54e-05	0.000475	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CYP19A1—esophageal cancer	6.42e-05	0.000466	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SST—esophageal cancer	6.4e-05	0.000465	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALOX15—esophageal cancer	6.39e-05	0.000464	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—EP300—esophageal cancer	6.31e-05	0.000458	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NOTCH3—esophageal cancer	6.24e-05	0.000453	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—GHRL—esophageal cancer	6.24e-05	0.000453	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SMAD4—esophageal cancer	6.19e-05	0.000449	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—PIK3CA—esophageal cancer	6.15e-05	0.000446	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FBXW7—esophageal cancer	6.14e-05	0.000445	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TGFBR2—esophageal cancer	6.11e-05	0.000443	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTO1—esophageal cancer	6.1e-05	0.000442	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—TPI1—esophageal cancer	6.1e-05	0.000442	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—TP53—esophageal cancer	5.95e-05	0.000432	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—HMOX1—esophageal cancer	5.86e-05	0.000425	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALDOB—esophageal cancer	5.85e-05	0.000424	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SMAD4—esophageal cancer	5.79e-05	0.00042	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—PIK3CA—esophageal cancer	5.75e-05	0.000417	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GAPDH—esophageal cancer	5.63e-05	0.000408	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ABCB1—esophageal cancer	5.62e-05	0.000408	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NOTCH2—esophageal cancer	5.6e-05	0.000406	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CRABP1—esophageal cancer	5.58e-05	0.000405	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—TP53—esophageal cancer	5.56e-05	0.000403	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GNG7—esophageal cancer	5.31e-05	0.000385	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HIF1A—esophageal cancer	5.07e-05	0.000368	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALDH2—esophageal cancer	4.97e-05	0.000361	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TGFBR2—esophageal cancer	4.97e-05	0.00036	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—KDR—esophageal cancer	4.85e-05	0.000352	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HIF1A—esophageal cancer	4.73e-05	0.000343	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTT1—esophageal cancer	4.73e-05	0.000343	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SMAD4—esophageal cancer	4.7e-05	0.000341	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP2A6—esophageal cancer	4.67e-05	0.000339	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—PIK3CA—esophageal cancer	4.67e-05	0.000339	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.66e-05	0.000338	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CREBBP—esophageal cancer	4.62e-05	0.000336	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NOTCH1—esophageal cancer	4.57e-05	0.000331	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—KDR—esophageal cancer	4.53e-05	0.000328	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—TP53—esophageal cancer	4.52e-05	0.000328	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ENO1—esophageal cancer	4.43e-05	0.000321	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PTGS1—esophageal cancer	4.43e-05	0.000321	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PSME1—esophageal cancer	4.37e-05	0.000317	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PSME2—esophageal cancer	4.37e-05	0.000317	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NOTCH1—esophageal cancer	4.27e-05	0.000309	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—NOS3—esophageal cancer	4.14e-05	0.0003	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CREBBP—esophageal cancer	4.14e-05	0.0003	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—EGFR—esophageal cancer	4.07e-05	0.000295	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—PIK3CA—esophageal cancer	3.89e-05	0.000282	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CREBBP—esophageal cancer	3.87e-05	0.000281	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HIF1A—esophageal cancer	3.85e-05	0.000279	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.81e-05	0.000277	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—EGFR—esophageal cancer	3.8e-05	0.000276	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PTGS2—esophageal cancer	3.79e-05	0.000275	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP1B1—esophageal cancer	3.77e-05	0.000273	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CREBBP—esophageal cancer	3.76e-05	0.000273	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NOS3—esophageal cancer	3.71e-05	0.000269	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KDR—esophageal cancer	3.68e-05	0.000267	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—PIK3CA—esophageal cancer	3.63e-05	0.000263	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP19A1—esophageal cancer	3.54e-05	0.000257	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PIK3CA—esophageal cancer	3.53e-05	0.000256	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ERBB2—esophageal cancer	3.47e-05	0.000252	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NOTCH1—esophageal cancer	3.46e-05	0.000251	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NOS3—esophageal cancer	3.46e-05	0.000251	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—NOS3—esophageal cancer	3.36e-05	0.000244	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PIK3CA—esophageal cancer	3.3e-05	0.000239	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ERBB2—esophageal cancer	3.24e-05	0.000235	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—HMOX1—esophageal cancer	3.23e-05	0.000235	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.17e-05	0.00023	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—EP300—esophageal cancer	3.15e-05	0.000229	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CREBBP—esophageal cancer	3.14e-05	0.000228	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ABCB1—esophageal cancer	3.1e-05	0.000225	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—EGFR—esophageal cancer	3.09e-05	0.000224	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PTGS2—esophageal cancer	3.08e-05	0.000223	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CCND1—esophageal cancer	3.06e-05	0.000222	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CDKN1A—esophageal cancer	2.96e-05	0.000215	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3CA—esophageal cancer	2.95e-05	0.000214	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CCND1—esophageal cancer	2.86e-05	0.000208	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—EP300—esophageal cancer	2.82e-05	0.000205	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NOS3—esophageal cancer	2.81e-05	0.000204	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CDKN1A—esophageal cancer	2.77e-05	0.000201	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CA—esophageal cancer	2.68e-05	0.000194	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—EP300—esophageal cancer	2.63e-05	0.000191	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ERBB2—esophageal cancer	2.63e-05	0.000191	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—EP300—esophageal cancer	2.56e-05	0.000186	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MYC—esophageal cancer	2.46e-05	0.000178	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—EGFR—esophageal cancer	2.4e-05	0.000174	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.35e-05	0.00017	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CA—esophageal cancer	2.33e-05	0.000169	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCND1—esophageal cancer	2.32e-05	0.000169	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MYC—esophageal cancer	2.3e-05	0.000167	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CDKN1A—esophageal cancer	2.25e-05	0.000163	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—EGFR—esophageal cancer	2.24e-05	0.000163	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—EP300—esophageal cancer	2.14e-05	0.000155	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CA—esophageal cancer	2.09e-05	0.000151	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CREBBP—esophageal cancer	2.07e-05	0.00015	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TP53—esophageal cancer	2.02e-05	0.000146	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CA—esophageal cancer	1.95e-05	0.000141	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CA—esophageal cancer	1.89e-05	0.000137	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TP53—esophageal cancer	1.88e-05	0.000137	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MYC—esophageal cancer	1.86e-05	0.000135	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—NOS3—esophageal cancer	1.86e-05	0.000135	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—EGFR—esophageal cancer	1.82e-05	0.000132	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PTGS2—esophageal cancer	1.7e-05	0.000123	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CA—esophageal cancer	1.58e-05	0.000115	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TP53—esophageal cancer	1.53e-05	0.000111	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—EP300—esophageal cancer	1.41e-05	0.000102	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CA—esophageal cancer	1.04e-05	7.58e-05	CbGpPWpGaD
